Entrada Therapeutics Inc (TRDA)

18.78 +0.73 (+4.04%) USD  |  NASDAQ  |  Nov 22, 11:22
More

Entrada Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Net Operating Assets Data

View and export this data back to 2023. Upgrade now.
Date Value
September 30, 2024 --
June 30, 2024 --
Date Value
March 31, 2024 --
December 31, 2023 --

Return on Net Operating Assets Range, Past 5 Years

Upgrade
Minimum
Dec 2023
Upgrade
Maximum
Jun 2024
Upgrade
Average
Upgrade
Median

Return on Net Operating Assets Benchmarks

Catalyst Pharmaceuticals Inc Upgrade
Vertex Pharmaceuticals Inc Upgrade
Assembly Biosciences Inc Upgrade
Sarepta Therapeutics Inc Upgrade
Regenxbio Inc Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade